本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

ZYVERSA THERAPEUTICS INC

0.6700
-0.0300-4.29%
盘后0.67060.0006+0.09%16:59 EDT
成交量:13.33万
成交额:9.04万
市值:319.82万
市盈率:-0.08
高:0.6919
开:0.6790
低:0.6680
收:0.7000
数据加载中...
2024/08/01

重要事件披露

Form 8-K - Current report
2024/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/15

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/04/25

重要事件披露

Form 8-K - Current report
2024/04/17

重要事件披露

Form 8-K - Current report
2024/03/25

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/08

重要事件披露

Form 8-K - Current report
2024/03/01

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/09

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/19

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/23

重要事件披露

Form 8-K - Current report
2023/12/11

重要事件披露

Form 8-K - Current report
2023/12/06

SEC问询函

Form CORRESP - Correspondence
2023/12/06

SEC问询函

Form CORRESP - Correspondence
2023/12/06

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/12/05

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/12/01

重要事件披露

Form 8-K - Current report